Open Innovation with Mount Sinai at the JP Morgan Healthcare Investment Conference
Over 250 healthcare investors, pharma / biotech partners and groundbreaking startups joined Mount Sinai to share successes and strategies that enhance innovation ecosystems last month at the JP Morgan Healthcare Investment Conference in San Francisco. Diversity is key Diversity has become a …
Life Science Development and the Future of Medicine: The Mount Sinai Perspective
Mount Sinai Innovation Partners (MSIP) participated in several conferences and events to wrap up 2019, gathering thought leaders and industry experts to discuss best practices on building a strong life science ecosystem for the purpose of helping patient populations. These events included …
Mount Sinai Innovation Partners Announces Inventor of the Year and Deal of the Year 2019
At the Innovation Awards Ceremony on October 14, Mount Sinai Innovation Partners (MSIP) presented the award for Inventor of the Year to Edward Schuchman, PhD, and Calogera (Lilla) Simonaro, PhD, and Deal of the Year to the RenalytixAI team at Mount Sinai: …
A Framework for the Pursuit of Innovation
Written by Sharlin Bird, Strategic Relations Specialist at KLAS Research In conversation with Erik Lium, PhD, Executive Vice President, Mount Sinai Innovation Partners (MSIP) Driving innovation in healthcare is a challenging endeavor. It is a market full of dynamic customers, a variety …
MSIP and NYEE Launch iLABS, Featuring the Latest Technology in Ophthalmic Care
The inaugural iLABS event took place on September 19, showcasing the latest technologies in ophthalmology from Mount Sinai Health System innovators. Hosted by the Mount Sinai Department of Ophthalmology, the New York Eye and Ear (NYEE) Infirmary Program for Innovation and Technology, …
Sinai BioDesign Hosts FDA Representative to Discuss Medical Device Submissions
Sinai BioDesign, an organization of the Icahn School of Medicine at Mount Sinai focused on the development of biomedical technologies, hosted U.S. Food and Drug Administration (FDA) representative Joshua Chetta on October 1 to discuss the regulations and requirements for device submission …
Moving Science into the Clinic
How Mount Sinai Drives Real-World Applications of Research Discoveries By Douglas McCormick From the fall issue of Mount Sinai Science & Medicine magazine The long-anticipated combination of artificial intelligence and molecular biology is now producing personalized, precision treatments for patients at Mount …
Life Science Academic Partnerships Part 1: an Ideal Marriage to Fuel Organic Growth
By Mark Ralph, Executive Director & Global Head, Contracts & Alliance Management, Boehringer Ingelheim Pharmaceuticals, Inc. In today’s innovation environment, external collaboration is one of the most powerful methods to discover and develop new treatments and research tools, particularly between industry and …